SEC Form DFiling only, no announcement found
Sinopia Biosciences, based in San Diego, CA, reported $2,818,079 sold in a private offering of equity and options or warrants, with the first sale on June 29, 2026, in a Form D filed with the SEC on July 16, 2026. The filing says 35 investors have already invested. The offering authorizes up to $4,253,094.
Legal name on the filing: Sinopia Biosciences, Inc..
| Amount sold | $2,818,079Basis: Form D total amount sold, as of the filing of July 16, 2026. Not the announced round size. |
|---|---|
| Total offering | $4,253,094The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $1,435,015 |
| Securities offered | Equity; Security to be acquired upon exercise of option, warrant or other right |
| Exemption claimed | Rule 506(b) |
| Date of first sale | June 29, 2026 |
| Investors already invested | 35 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Biotechnology |
| Principal place of business | San Diego, CA |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | over five years ago |
| Revenue range | Decline to Disclose |
| SEC CIK | 2145708 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Aarash Bordbar | Executive Officer, Director | None linked |
| Arthur T Suckow | Director | None linked |
| Bernhard Palsson | Director | None linked |
| Iman Famili | Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Jul 16, 2026 | D (original) | $2,818,079 | $4,253,094 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Sinopia Biosciences: SEC Form D deal record", https://vcbeast.com/deals/sinopia-biosciences-form-d-2026-06-29. Source: SEC EDGAR, accession 0002145708-26-000001.